Public Procurement of Medicines in Europe: Key Findings and Best Practices
Experts in the Pharmacoeconomics Department recently conducted a study on the best practices in the public procurement of medicines. Commissioned by the European Commission, this study aims to improve access to medicines, affordability, availability, and more.
Public procurement of medicines can improve access, foster competition, and address important policy objectives. This study mapped and analyzed PPM practices across 32 European countries, revealing some fascinating insights.
Findings include:
- Different organizational forms of procurement, ranging from facility-based to centralized procurement.
- Use of various procedures and techniques, including the Most Economically Advantageous Tender
- Specific forms of procurement in the hospital sector
- Impacts on policy objectives, such as access to medicines and environmental protection
- Best practices for optimizing PPM in Europe
Discover the full report for a comprehensive understanding of PPM practices in Europe on the below link. Let’s work together to ensure affordable and accessible medicines for all!
Recent Posts
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft Annual Work Programm...
How will the EU Health Technology Assessment framework evolve in 2026 to improve clinical evaluations for cancer treatments and advanced therapies? The EU Health Technology Assessment (HTA) initiative coordinates standardized reviews of medicines and devices across Member States, thereby boosting...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
What does the latest WHO guideline reveal about GLP-1 obesity therapies, as released in December 2025? This landmark document establishes the first global standards for integrating glucagon-like peptide-1 (GLP-1) receptor agonists and GIP/GLP-1 dual agonists into chronic obesity management, treat...
Strengthening EU Pharmaceutical Supply Security Through the Critical Medicines Act
Enhancing EU Supply Security for Essential Pharmaceuticals
The EU's Critical Medicines Act proposal is a key initiative to strengthen EU pharmaceutical supply security amid ongoing shortages of vital drugs like antibiotics,...